162 related articles for article (PubMed ID: 36757555)
1. Cost-effectiveness of IVF with PGT-M/A to prevent transmission of spinal muscular atrophy in offspring of carrier couples.
Khorshid A; Boyd ALH; Behr B; Zhao Q; Alvero R; Bavan B
J Assist Reprod Genet; 2023 Apr; 40(4):793-801. PubMed ID: 36757555
[TBL] [Abstract][Full Text] [Related]
2. Cost effectiveness of in vitro fertilisation and preimplantation genetic testing to prevent transmission of BRCA1/2 mutations.
Lipton JH; Zargar M; Warner E; Greenblatt EE; Lee E; Chan KKW; Wong WWL
Hum Reprod; 2020 Feb; 35(2):434-445. PubMed ID: 32099994
[TBL] [Abstract][Full Text] [Related]
3. Clinical validity and utility of preconception expanded carrier screening for the management of reproductive genetic risk in IVF and general population.
Capalbo A; Fabiani M; Caroselli S; Poli M; Girardi L; Patassini C; Favero F; Cimadomo D; Vaiarelli A; Simon C; Rienzi LF; Ubaldi FM
Hum Reprod; 2021 Jun; 36(7):2050-2061. PubMed ID: 34021342
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of preimplantation genetic testing for aneuploidy for women with subfertility in China: an economic evaluation using evidence from the CESE-PGS trial.
He X; Wang X; Shen J; Wan B; Wang Y; Zhang Z; Cai L; Bao Y; Ding H; Li X
BMC Pregnancy Childbirth; 2023 Apr; 23(1):254. PubMed ID: 37060068
[TBL] [Abstract][Full Text] [Related]
5. In vitro fertilization with preimplantation genetic testing for monogenetic diseases versus unassisted conception with prenatal diagnosis for Huntington disease: a cost-effectiveness analysis.
Christensen AA; Parker PB; Hersh AR; Caughey AB; Krieg SA
Fertil Steril; 2022 Jul; 118(1):56-64. PubMed ID: 35618525
[TBL] [Abstract][Full Text] [Related]
6. Preimplantation genetic testing for BRCA gene mutation carriers: a cost effectiveness analysis.
Michaan N; Leshno M; Cohen Y; Safra T; Peleg-Hasson S; Laskov I; Grisaru D
Reprod Biol Endocrinol; 2021 Oct; 19(1):153. PubMed ID: 34620184
[TBL] [Abstract][Full Text] [Related]
7. Preimplantation genetic testing for aneuploidy is cost-effective, shortens treatment time, and reduces the risk of failed embryo transfer and clinical miscarriage.
Neal SA; Morin SJ; Franasiak JM; Goodman LR; Juneau CR; Forman EJ; Werner MD; Scott RT
Fertil Steril; 2018 Oct; 110(5):896-904. PubMed ID: 30316435
[TBL] [Abstract][Full Text] [Related]
8. Preimplantation genetic diagnosis versus prenatal diagnosis-decision-making among pregnant FMR1 premutation carriers.
Haham LM; Avrahami I; Domniz N; Ries-Levavi L; Berkenstadt M; Orvieto R; Cohen Y; Elizur SE
J Assist Reprod Genet; 2018 Nov; 35(11):2071-2075. PubMed ID: 30136016
[TBL] [Abstract][Full Text] [Related]
9. Minimizing mosaicism: assessing the impact of fertilization method on rate of mosaicism after next-generation sequencing (NGS) preimplantation genetic testing for aneuploidy (PGT-A).
Palmerola KL; Vitez SF; Amrane S; Fischer CP; Forman EJ
J Assist Reprod Genet; 2019 Jan; 36(1):153-157. PubMed ID: 30362056
[TBL] [Abstract][Full Text] [Related]
10. Preimplantation genetic testing for aneuploidies (abnormal number of chromosomes) in in vitro fertilisation.
Cornelisse S; Zagers M; Kostova E; Fleischer K; van Wely M; Mastenbroek S
Cochrane Database Syst Rev; 2020 Sep; 9(9):CD005291. PubMed ID: 32898291
[TBL] [Abstract][Full Text] [Related]
11. Pregnancy outcomes following in vitro fertilization frozen embryo transfer (IVF-FET) with or without preimplantation genetic testing for aneuploidy (PGT-A) in women with recurrent pregnancy loss (RPL): a SART-CORS study.
Bhatt SJ; Marchetto NM; Roy J; Morelli SS; McGovern PG
Hum Reprod; 2021 Jul; 36(8):2339-2344. PubMed ID: 34027546
[TBL] [Abstract][Full Text] [Related]
12. Clinical utility of combined preimplantation genetic testing methods in couples at risk of passing on beta thalassemia/hemoglobin E disease: A retrospective review from a single center.
Satirapod C; Sukprasert M; Panthan B; Charoenyingwattana A; Chitayanan P; Chantratita W; Choktanasiri W; Trachoo O; Hongeng S
PLoS One; 2019; 14(11):e0225457. PubMed ID: 31751397
[TBL] [Abstract][Full Text] [Related]
13. Preimplantation genetic testing for sickle cell disease: a cost-effectiveness analysis.
Combs JC; Dougherty M; Yamasaki MU; DeCherney AH; Devine KM; Hill MJ; Rothwell E; O'Brien JE; Nelson RE
F S Rep; 2023 Sep; 4(3):300-307. PubMed ID: 37719105
[TBL] [Abstract][Full Text] [Related]
14. Mosaic embryo transfer versus additional IVF with PGT-A Cycle: a decision model comparing live birth rate and cost.
Khorshid A; Bavan B; Chung EH; Lathi RB
J Assist Reprod Genet; 2024 Mar; 41(3):635-641. PubMed ID: 38231287
[TBL] [Abstract][Full Text] [Related]
15. Preimplantation Genetic Testing for Monogenic Disease of Spinal Muscular Atrophy by Multiple Displacement Amplification: 11 unaffected livebirths.
Fu Y; Shen X; Wu H; Chen D; Zhou C
Int J Med Sci; 2019; 16(9):1313-1319. PubMed ID: 31588198
[No Abstract] [Full Text] [Related]
16. Sonographic abnormalities in pregnancies conceived following IVF with and without preimplantation genetic testing for aneuploidy (PGT-A).
Riestenberg CK; Mok T; Ong JR; Platt LD; Han CS; Quinn MM
J Assist Reprod Genet; 2021 Apr; 38(4):865-871. PubMed ID: 33534049
[TBL] [Abstract][Full Text] [Related]
17. Beyond the biopsy: predictors of decision regret and anxiety following preimplantation genetic testing for aneuploidy.
Goldman KN; Blakemore J; Kramer Y; McCulloh DH; Lawson A; Grifo JA
Hum Reprod; 2019 Jul; 34(7):1260-1269. PubMed ID: 31220868
[TBL] [Abstract][Full Text] [Related]
18. A cost-effectiveness analysis of preimplantation genetic testing for aneuploidy (PGT-A) for up to three complete assisted reproductive technology cycles in women of advanced maternal age.
Lee E; Costello MF; Botha WC; Illingworth P; Chambers GM
Aust N Z J Obstet Gynaecol; 2019 Aug; 59(4):573-579. PubMed ID: 31106861
[TBL] [Abstract][Full Text] [Related]
19. An economic analysis of preimplantation genetic testing for aneuploidy by polar body biopsy in advanced maternal age.
Neumann K; Sermon K; Bossuyt P; Goossens V; Geraedts J; Traeger-Synodinos J; Parriego M; Schmutzler A; van der Ven K; Rudolph-Rothfeld W; Vonthein R; Griesinger G
BJOG; 2020 May; 127(6):710-718. PubMed ID: 31930663
[TBL] [Abstract][Full Text] [Related]
20. Impact of in vitro fertilization-preimplantation genetic testing (IVF-PGT) funding policy on clinical outcome: An issue that stems beyond effectiveness of treatment.
Shao YH; Zhang XY; Buckett W; Ao A
Eur J Obstet Gynecol Reprod Biol; 2019 Apr; 235():1-5. PubMed ID: 30743159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
